Correlation Between SAB Biotherapeutics and First Wave
Can any of the company-specific risk be diversified away by investing in both SAB Biotherapeutics and First Wave at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining SAB Biotherapeutics and First Wave into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between SAB Biotherapeutics and First Wave BioPharma, you can compare the effects of market volatilities on SAB Biotherapeutics and First Wave and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in SAB Biotherapeutics with a short position of First Wave. Check out your portfolio center. Please also check ongoing floating volatility patterns of SAB Biotherapeutics and First Wave.
Diversification Opportunities for SAB Biotherapeutics and First Wave
-0.38 | Correlation Coefficient |
Very good diversification
The 3 months correlation between SAB and First is -0.38. Overlapping area represents the amount of risk that can be diversified away by holding SAB Biotherapeutics and First Wave BioPharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on First Wave BioPharma and SAB Biotherapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on SAB Biotherapeutics are associated (or correlated) with First Wave. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of First Wave BioPharma has no effect on the direction of SAB Biotherapeutics i.e., SAB Biotherapeutics and First Wave go up and down completely randomly.
Pair Corralation between SAB Biotherapeutics and First Wave
If you would invest 269.00 in SAB Biotherapeutics on August 25, 2024 and sell it today you would earn a total of 44.00 from holding SAB Biotherapeutics or generate 16.36% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 4.55% |
| Values | Daily Returns |
SAB Biotherapeutics vs. First Wave BioPharma
Performance |
| Timeline |
| SAB Biotherapeutics |
| First Wave BioPharma |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
SAB Biotherapeutics and First Wave Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with SAB Biotherapeutics and First Wave
The main advantage of trading using opposite SAB Biotherapeutics and First Wave positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if SAB Biotherapeutics position performs unexpectedly, First Wave can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in First Wave will offset losses from the drop in First Wave's long position.| SAB Biotherapeutics vs. Processa Pharmaceuticals | SAB Biotherapeutics vs. Third Harmonic Bio | SAB Biotherapeutics vs. Cingulate Warrants | SAB Biotherapeutics vs. Anebulo Pharmaceuticals |
| First Wave vs. Quoin Pharmaceuticals Ltd | First Wave vs. Revelation Biosciences | First Wave vs. Dermata Therapeutics | First Wave vs. LMF Acquisition Opportunities |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.
Other Complementary Tools
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum |